Insurance Fraud Accountability Act
- Bill Number
- S. 976
- Origin Chamber
- Senate
- Congress
- 119th Congress, Session 1
- Policy Area
- Health
- Status
- Introduced
- Latest Action
- 2025-11-06: Committee on Homeland Security and Governmental Affairs Senate Permanent Subcommittee on Investigations. Hearings held.
- Last Updated
- 2026-03-18T11:03:17Z
AI-Generated Summary
Purpose
The Insurance Fraud Accountability Act (S. 976) aims to amend the Patient Protection and Affordable Care Act (ACA, also known as Obamacare) to prevent fraudulent enrollments in qualified health plans (insurance plans available through government-run health insurance marketplaces, or Exchanges). It focuses on increasing accountability for agents, brokers, and marketing organizations involved in enrollments, while protecting consumers from unauthorized changes to their coverage.
Key Provisions
- Penalties for Agents and Brokers:
- Introduces civil penalties of $10,000 to $50,000 per affected individual for negligent or reckless provision of incorrect information during enrollments.
- Establishes higher civil penalties up to $200,000 per individual for knowingly providing false or fraudulent information, with procedures similar to those under the Social Security Act for imposing fines.
- Adds criminal penalties, including fines under federal law and up to 10 years in prison, for willful fraud in enrollment applications.
- Consumer Protections in Enrollments:
- Requires the Secretary of Health and Human Services (HHS) to create a verification process for new enrollments or coverage changes submitted by agents or brokers in federally operated Exchanges (starting no later than January 1, 2029).
- Key requirements include: proof of consumer consent (e.g., via a standardized form), delayed payment of commissions until any enrollment issues are resolved, access to enrollment details via databases or websites/hotlines, timely notifications of changes with instructions for cancellations, and reporting of involved marketing organizations.
- Emphasizes maintaining coverage continuity, prohibiting disenrollment without consumer consent even if violations occur.
- Regulation of Marketing Organizations:
- Defines and regulates "field marketing organizations" (entities that employ or contract with agents/brokers for enrollment functions) and "third-party marketing organizations" (entities paid for lead generation, marketing, or sales related to enrollments).
- Sets criteria for states to allow these organizations in the "chain of enrollment" (steps from marketing to final enrollment decision), including acting in consumers' best interests, reporting terminations (end of contracts or arrangements), meeting marketing standards, avoiding misleading practices, submitting materials for HHS review, licensure, registration, and proper compensation rules.
- Requires reporting of issuer terminations (end of insurance company participation) to HHS.
- Transparency and Oversight:
- Mandates periodic audits of agents and brokers based on complaints, fraud patterns, or other factors, with results shared and potential fraud referred to state insurance departments (starting no later than January 1, 2029).
- Requires HHS to maintain and share lists of suspended or terminated agents and brokers with Exchanges, states, and health plans.
Significant Changes to Existing Law
- Expands penalties under ACA Section 1411(h) to specifically target agents and brokers with tiered civil and new criminal sanctions for fraud or negligence, beyond general penalties for incorrect information.
- Adds a new ACA Section 1311(c)(8) for mandatory enrollment verification in federally run Exchanges, including consent and notification rules not previously required.
- Amends ACA Section 1312(e) to formally regulate field and third-party marketing organizations, introducing definitions, criteria, and oversight not explicitly covered before.
- Introduces audit processes and shared lists under ACA Section 1312(e), enhancing federal and state coordination without limiting existing enforcement tools.
Potential Impacts
- On Government Agencies: Increases HHS's role in verification, regulation, audits, and data sharing, potentially raising administrative costs but improving fraud detection in Exchanges. States gain tools for oversight but must align with federal criteria.
- On Citizens: Enhances protections against unauthorized enrollments or changes, reducing fraud risks for individuals seeking ACA coverage; promotes transparency via notifications and access to account info, potentially leading to fewer coverage disruptions.
- On International Relations: No direct impacts, as the bill focuses on domestic health insurance marketplaces.
Main Stakeholders Affected
- Consumers/Enrollees: Primary beneficiaries through fraud prevention and coverage safeguards.
- Agents, Brokers, and Marketing Organizations: Face stricter compliance, penalties, and reporting requirements, which could limit bad actors but increase operational burdens for legitimate ones.
- Health Insurance Issuers and Exchanges: Benefit from verified enrollments and shared lists to reduce improper payments/commissions; must integrate new data access.
- States and HHS: States handle licensure and local enforcement; HHS oversees federal standards, audits, and processes in federally facilitated Exchanges.
- National Association of Insurance Commissioners: Consulted on audits, influencing state-federal coordination.
Notable Legal, Constitutional, or Political Implications
- Legal: Strengthens civil and criminal enforcement against fraud in ACA programs, aligning with broader federal anti-fraud laws (e.g., Social Security Act procedures); clarifies "best interests" duty for agents, potentially leading to more litigation over compliance but without creating new private rights of action.
- Constitutional: No apparent challenges; amendments fall within Congress's commerce clause authority over interstate insurance and federal spending on health programs.
- Political: Builds on ACA by addressing vulnerabilities in marketplace operations, appealing to efforts to protect consumer access amid ongoing debates over healthcare affordability; could face opposition from industry groups over added regulations, but supports bipartisan anti-fraud goals.
This summary was generated by AI and may contain inaccuracies. Refer to the official source document for the authoritative text.
Sponsor
Cosponsors (11)
Sen. Duckworth, Tammy [D-IL], Sen. Hirono, Mazie K. [D-HI], Sen. Klobuchar, Amy [D-MN], Sen. Murray, Patty [D-WA], Sen. Schatz, Brian [D-HI], Sen. Shaheen, Jeanne [D-NH], Sen. Smith, Tina [D-MN], Sen. Welch, Peter [D-VT], Sen. Van Hollen, Chris [D-MD], Sen. Blumenthal, Richard [D-CT], Sen. Warnock, Raphael G. [D-GA]
Recent Actions
- 2025-11-06: Committee on Homeland Security and Governmental Affairs Senate Permanent Subcommittee on Investigations. Hearings held.
- 2025-03-12: Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
- 2025-03-12: Introduced in Senate
Bill Versions
- Insurance Fraud Accountability Act — issued 2025-03-12 — PDF (17 pages)